← Product Code LZJ · K102549 # THE ASCENSION MOVEMENT GREAT TOE SYSTEM TOTAL ARTHROPLASTY (K102549) _Ascension Orthopedics, Inc. · LZJ · Dec 21, 2010 · OR · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K102549 ## Device Facts - **Applicant:** Ascension Orthopedics, Inc. - **Product Code:** LZJ - **Decision Date:** Dec 21, 2010 - **Decision:** SESE - **Submission Type:** Traditional - **Device Class:** Class U - **Review Panel:** OR - **Attributes:** Therapeutic ## Intended Use The Ascension® MOVEMENT™ Great Toe System, Total Arthroplasty is a two-piece implant that is intended to be used as prosthesis for the metatarso-phalangeal ioint (MTP). The device is intended for cemented use only. Indications for use include: - . Painful degenerative metatarso-phalangeal joint change - . Hallux rigidus stage 3 and 4 - . Hallux valqus and hallux rigidus - . Hallux limitus with painful arthrofibrosis - . Revisions after moderate proximal phalanx resection ## Device Story Two-piece, semi-constrained, metal/polymer total arthroplasty prosthesis for 1st metatarso-phalangeal (MTP) joint. Device resurfaces MTP joint base; couples with Ascension metatarsal hemi-arthroplasty device. Features four anatomically designed base geometries with cylindrical stems and tapered ribs for rotational/axial stability. Designed for cemented fixation. Delivered sterile for single use. Used by orthopedic surgeons in clinical/surgical settings. Instrumentation provided for precise implant preparation. Benefits include restoration of joint function and pain relief in patients with degenerative or structural toe conditions. ## Clinical Evidence Bench testing only. No clinical data provided. Equivalence supported by geometrical comparisons and mechanical strength testing (interconnection, axial, shear, and bending). ## Technological Characteristics Two-piece, semi-constrained metal/polymer prosthesis. Features cylindrical stems with tapered ribs. Designed for cemented fixation. Sterile, single-use. No specific material standards or software algorithms described. ## Predicate Devices - KGTI™ Kinetik Great Toe Implant System ([K924724](/device/K924724.md)) - Merete ToeMobile™ Anatomical Great Toe Resurfacing System ([K072251](/device/K072251.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K102549 1/2 # 501(k) Summary # DEC 2 1 2010 . | SUBMITTER NAME: | Ascension Orthopedics, Inc.
8700 Cameron Road, #100
Austin, TX 78754-3832 | |---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 510(k) CONTACT: | Susan Walton
Phone: (512) 836-5001 x1591 | | TRADE NAME: | Ascension® MOVEMENT Great Toe System | | COMMON NAME: | prosthesis, toe (metatarso-phalangeal), joint,
metal/polymer, semi-constrained | | CLASSIFICATION: | unclassified | | PRODUCT CODE: | LZJ | | PANEL: | Orthopedic | | PREDICATE DEVICES: | KGTI™ Kinetik Great Toe Implant System,
Integra Lifesciences, K924724 | | | Merete ToeMobile™ Anatomical Great Toe
Resurfacing System, Merete Medical,
K072251 | | DEVICE DESCRIPTION: | The Ascension® MOVEMENT Great Toe
System, Total Arthroplasty device is an
anatomically designed, semi-constrained,
two-piece device designed for resurfacing of
the base of the 1st metatarso-phalangeal
(MTP) joint. The device couples with the
Ascension metatarsal hemi-arthroplasty
device to allow total arthroplasty of the 1st
MTP joint. The device is designed for
cemented fixation. The device is boxed
individually and delivered sterile for single
use. The device incorporates four
anatomically designed base geometries with
appropriately sized stems. The stem is
cylindrical with tapered ribs to provide
rotational as well as axial stability of the
seated implant. System instrumentation is
designed to offer precise implant preparation. | . {1}------------------------------------------------ 77 #### INTENDED USE: The Ascension® MOVEMENT™ Great Toe System, Total Arthroplasty is a two-piece implant that is intended to be used as prosthesis for the metatarso-phalangeal ioint (MTP). The device is intended for cemented use only. Indications for use include: - . Painful degenerative metatarsophalangeal joint change - . Hallux rigidus stage 3 and 4 - . Hallux valqus and hallux rigidus - . Hallux limitus with painful arthrofibrosis - . Revisions after moderate proximal phalanx resection Substantial equivalence was based upon testing and a geometrical comparison of the subject and predicate devices. Interconnection strength testing, axial, shear and bending strength, was performed to substantiate equivalence. Geometrical comparisons between the subject device, Ascension® MOVEMENT™ Great Toe System and Integra KGTI™ Kinetik Great Toe Implant System (K904724) were completed. The Merete ToeMobile Anatomical Great Toe Resurfacing System (K072251) was used as a template for labeled indications. There are no significant differences between the Ascension MOVEMENT Great Toe System and other systems currently being marketed which would adversely affect the use of the product. It is substantially equivalent to these other devices in design. function, material and intended use. #### BASIS OF SUBSTANTIAL EQUIVALENCE: {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a stylized eagle or bird symbol, with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the bird symbol. Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002 DEC 2 1 , 2010 Ascension Orthopedics, Inc. % Ms. Susan Walton 8700 Cameron Road, #100 Austin, TX 78754-3832 Re: K102549 Trade/Device Name: Ascension MOVEMENT Great Toe System Regulation Number: Unclassified Regulation Name: Prosthesis, Toe (metatarso-phalangeal), Joint, Metal/polymer, Semiconstrained Regulatory Class: Unclassified Product Code: LZJ Dated: December 9, 2010 Received: December 10, 2010 Dear Ms. Walton: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {3}------------------------------------------------ #### Page 2 – Ms. Susan Walton forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/Reportal?roblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours. AC. B. 2. h Din Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use 510(K) Number. Kj02549 Device Name: Ascension® MOVEMENT™ Great Toe System Indications for Use: The Ascension® MOVEMENT™ Great Toe System, Total Arthroplasty is a twopiece implant that is intended to be used as prosthesis for the metatarsophalangeal joint (MTP). The device is intended for cemented use only. Indications for use include: - Painful degenerative metatarso-phalangeal joint change . - Hallux rigidus stage 3 and 4 ◆ - Hallux valgus and hallux rigidus . - Hallux limitus with painful arthrofibrosis . - Revisions after moderate proximal phalanx resection . Prescription Use x (Part 21 CFR 801Subpart B) OR Over-The-Counter Use (Part 21 CFR 801Subpart C) ## (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY) Concurrence of CDRH, Office of Device Evaluation (ODE) M. Melkerson Division Sign Off (Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices Page 1 of 510(k) Number K102549 --- **Source:** [https://fda.innolitics.com/device/K102549](https://fda.innolitics.com/device/K102549) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com